Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients
This study has been completed.
Study NCT00616551   Information provided by Ambrilia Biopharma, Inc.

First Received on February 4, 2008.   Last Updated on October 7, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial